Memo Therapeutics AG
Memo Therapeutics AG is a Swiss Biotech company based in Schlieren (Zurich). It holds no Swissmedic authorisations for human medicines of its own and is listed here as a Biotech.
Key facts
| Sector | Biotech |
|---|---|
| City | Schlieren |
| Canton | Zurich |
| Authorisation holder | No |
| Medicines | Not available |
| Founded | 2012 |
| Employees | 11-50 |
| Parent group | Not available |
| Activity | antibody discovery and antiviral monoclonal antibody development |
| Website | memo-therapeutics.com |
Medicines authorised in Switzerland
No medicine authorisation
Memo Therapeutics AG is not recorded as an authorisation holder for human medicines with Swissmedic. That is normal for device manufacturers, contract manufacturers, wholesalers, laboratories and consultancies.
Biotechnological products, blood products, vaccines, cell and gene therapies and allergens.
Frequently asked questions
How many medicines does Memo Therapeutics AG have authorised in Switzerland?
Memo Therapeutics AG holds no Swissmedic authorisations for human medicines (as of 1 September 2026). The company is listed here as a Biotech business.
Where is Memo Therapeutics AG based?
The Swiss location recorded for Memo Therapeutics AG is Schlieren, Zurich.
Is Memo Therapeutics AG a Swissmedic authorisation holder?
No. Memo Therapeutics AG does not appear as an authorisation holder in the Swissmedic list. To reach the Swiss market, a foreign manufacturer needs an authorisation holder domiciled or represented in Switzerland.